Article Text

Download PDFPDF

Pituitary apoplexy complicated by vasospasm and bilateral cerebral infarction
Free
  1. Giulio Gambaracci1,
  2. Valeria Rondoni1,
  3. Giorgio Guercini2,
  4. Piero Floridi2
  1. 1Department of Radiology, Surgical and Biomedical Sciences, Division of Radiology 2, Perugia University, Perugia, Italy
  2. 2Department of Neuroradiology, Santa Maria della Misericordia Hospital, Perugia, Italy
  1. Correspondence to Dr Giulio Gambaracci, giulio.gambaracci{at}libero.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

Pituitary apoplexy (PA) is a clinical syndrome caused by acute haemorrhage or infarction of the pituitary gland, generally within a pituitary adenoma, and manifests as visual impairment, severe headache, meningeal irritation, consciousness disturbance and hormonal dysfunction.1 Cerebral infarction secondary to arterial vasospasm is an extremely rare complication of PA, and only a few cases have been reported.2 ,3

A 55-year-old postmenopausal woman was admitted to the emergency department, with worsening headache and decreased visual acuity. An unenhanced CT scan detected a 3 cm pituitary mass without signs of subarachnoid haemorrhage (SAH). Two days later, she developed fever (39.1°C), and a second CT showed a larger hyperdense sellar mass, suggesting intralesional bleeding of a pituitary adenoma with secondary hypothalamus compression. Laboratory analyses revealed increased erythrocyte sedimentation rate (64 mm/hour) and pituitary hypofunction (table 1). The patient became lethargic, and a subsequent brain MRI examination confirmed the presence of a giant haemorrhagic sellar mass (figure 1) with mild meningeal enhancement, indicative of meningeal irritation. A focal cerebral oedema without signs of restriction was also noted in the left mesial temporal region on diffusion-weighted imaging (DWI). Trans-sphenoidal decompression and tumour excision were performed 3 days after the diagnosis of PA. A second MRI scan (completed the same day for difficult post-operative awakening) detected bilateral extensive ischaemic lesions with DWI restriction affecting the territory of the basilar artery (right cerebellum) and middle-anterior cerebral artery (figure 2), and associated with arterial vasospasm (figure 3) without signs of SAH.

Table 1

Hormone levels

Figure 1

Sagittal section of MRI T1-weighted scan showing haemorrhagic sellar mass (red arrowheads), with suprasellar extension.

Figure 2

DWI and FLAIR axial sections detected extensive bilateral ischaemic lesions of the internal capsule, basal ganglia (red arrows) and right frontoinsular-temporal region (A,B). The same features were also noted in the temporal lobe bilaterally (white arrows) and right cerebellum (red arrowheads; C,D). DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery.

Figure 3

MR angiography showing diffuse narrowing of the bilateral intracranial arteries, especially in the anterior (red arrows) and posterior (white arrowheads) circulation.

Learning points

  • Bilateral cerebral infarction secondary to arterial vasospasm—even though extremely rare—should not be overlooked as a possible complication of pituitary apoplexy.

  • To the best of our knowledge, the present case is one of the few reported in which ischaemic injury also affected a part of the basilar artery territory.

  • Cerebral vasospasm should not be attributed solely to subarachnoid haemorrhage, as it may be related to other factors, including intraoperative arterial manipulation or the release of vasoactive substances from a haemorrhagic adenoma or a compressed hypothalamus.

References

View Abstract

Footnotes

  • Contributors GGa and GGu substantially contributed to the analysis and interpretation of data for the study, drafted the manuscript, approved the final version and are accountable for all aspects of the study. VR substantially contributed to the design and acquisition of data for the study, revised the manuscript, approved the final version and is accountable for all aspects of the study. PF substantially contributed to the conception and acquisition of data for the study, revised the manuscript, approved the final version and is accountable for all aspects of the study.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.